Warren B. Kanders - 16 Jun 2026 Form 4 Insider Report for Cadre Holdings, Inc. (CDRE)

Reporting relationship: CEO AND CHAIRMAN, Director, 10%+ Owner
Issuer ticker: CDRE
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:15:18 UTC
Prior SEC filing: 17 Jun 2026
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Warren B. Kanders

Key filing fact

Warren B. Kanders filed Form 4 for Cadre Holdings, Inc. (CDRE) on 18 Jun 2026.

Key facts

This page summarizes Warren B. Kanders's Form 4 filing for Cadre Holdings, Inc. (CDRE).
4 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:15.

Change

Previous filing in this sequence was filed on 17 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000935577 Primary reporting owner

KANDERS WARREN B

Relationship: CEO AND CHAIRMAN, Director, 10%+ Owner
Address: C/O KANDERS & COMPANY, INC., 250 ROYAL PALM WAY, SUITE 201, PALM BEACH
Signature: /s/ Warren B. Kanders
Signature date: 18 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDRE transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +261,000
Change %
Price: $0.000000^*
Shares after: 261,000
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 261,000
Exercise price
Footnotes: F1

CDRE transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +373,000
Change %
Price: $0.000000^*
Shares after: 373,000
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 373,000
Exercise price
Footnotes: F2

CDRE transaction Derivative

Stock Option (right to purchase)

Award

Transaction value
Shares: +496,500
Change %
Price: $0.000000^*
Shares after: 496,500
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 496,500
Exercise price: $28.75
Footnotes: F3

CDRE transaction Derivative

Stock Option (right to purchase)

Award

Transaction value
Shares: +616,500
Change %
Price: $0.000000^*
Shares after: 616,500
Date: 16 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 616,500
Exercise price: $28.75
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents an award of restricted stock units granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan (the "Plan"), consisting of 261,000 restricted stock units relating to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), all of which will vest if, on or before June 16, 2033, the Common Stock achieves a volume-weighted average trading price ("VWAP") of at least $60.00 per share over a 20 consecutive trading day measurement period.

Footnote F2

Represents an award of restricted stock units granted under the Plan, consisting of 373,000 restricted stock units relating to shares of the Issuer's Common Stock, all of which will vest if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period.

Footnote F3

The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 496,500 shares of the Issuer's Common Stock will vest and become exercisable if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $60.00 per share over a 20 consecutive trading day measurement period.

Footnote F4

The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 616,500 shares of the Issuer's Common Stock will vest and become exercisable if, on or before June 16, 2033, the Common Stock achieves a VWAP of at least $80.00 per share over a 20 consecutive trading day measurement period.